WayneJMorganMD

Pediatric Pulmonology • Tucson, AZ

Professor of Pediatrics, University Ariz College of Medicine

Join to view full profile

Dr. Morgan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Morgan's full profile

Already have an account?

Office
535 N Wilmot Rd
Suite #101
Tucson, AZ 85711
Phone+1 520-694-9988

Fax+1 520-694-9917

Education & Training

University of Arizona College of Medicine-TucsonFellowship, Pulmonary Disease and Critical Care Medicine, 1981 - 1982
McGill University Faculty of MedicineClass of 1976

Certifications & Licensure

AZ State Medical License 1982 - 2026
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Pulmonology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Top Doctors:Arizona State Castle Connolly, 2013

Clinical Trials

Methods of Determining Asthma Severity in Children Start of enrollment: 2003 Nov 01
Completed
Inner-City Anti-IgE Therapy for Asthma Start of enrollment: 2006 Oct 01
Completed
Phase 4
The EPIC Observational Study Start of enrollment: 2004 Oct 01
Completed
Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis Start of enrollment: 2009 May 01
Completed
Not Applicable
Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness Start of enrollment: 2017 Jan 03
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Factors associated with prescription of elexacaftor/tezacaftor/ivacaftor among people with cystic fibrosis aged 12 years or older with at least one F508del allele.
Georgene E Hergenroeder, Jonathan V Todd, Josh S Ostrenga, Christopher H Goss, Raksha Jain
Journal of Cystic Fibrosis. 2025-01-01
Treatment of small as well as large declines in lung function enhances recovery to baseline in people with CF.
Michael S Schechter, Joshua S Ostrenga, Elizabeth A Cromwell, Clement L Ren, Aliza K Fink
Pediatric Pulmonology. 2024-12-01
1 citations
Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USA.
Elizabeth A Cromwell, Josh S Ostrenga, Don B Sanders, Wayne Morgan, Carlo Castellani
The European Respiratory Journal. 2024-11-01

Journal Articles

Original Article Phenotypes of Recurrent Wheezing in Preschool Children: Identification by Latent Class Analysis and Utility in Prediction of Future Exacerbation
Wayne Morgan, Daniel J Jackson, Michael D Cabana, Avraham Beigelman, Leonard B Bacharier, Robert S Zeiger, Stanley J Szefler, Fernando D Martinez, ScienceDirect
Health Insurance and Use of Recommended Routine Care in Adults with Cystic Fibrosis
Joseph D Tobias, Don Jr Hayes, Wayne J Morgan, Susan S Li, The Clinical Respiratory Journal

Press Mentions

Data That Empower: The Success and Promise of CF Patient RegistriesSeptember 14th, 2019